🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎉We've hit a combined 250,000 followers across all our platforms — and it’s all thanks to you! From sharing insights to advancing patient care, our global community of HCPs, researchers & partners makes it all possible Here’s to continuing the journey — together 💙 #ThankYou

🌍 Today on #ECND25 we celebrate cancer nurses uniting across Europe. Cancer knows no borders—neither should our care. Together, we’re breaking barriers, building bridges, and advancing cancer nursing for all. 💙 📖 Read our latest blog: touchoncology.com/insight/challe…

Revisited 🌟 Dr. Alexandra Leary & Dr. Juan Francisco Grau discuss the evolving role of immunotherapy in treating advanced/recurrent endometrial cancer. 🔹 ICIs in treatment 🔹 Patient management strategies 🔹 Emerging data shaping EC care 🎥 touchoncologyime.org/in-conversatio…

📢 Just published: touchREVIEWS in Oncology & Haematology Vol. 21, Issue 1 (2025)! Explore expert updates on AML, lymphoma, melanoma, lung & head & neck cancers, and more. 🔗 touchoncology.com/journals/touch… #Oncology #Haematology #MedicalEducation #DigitalMedEd

🎯 Precision, empathy & paediatric radiotherapy Dr Andrada Turcas, a touchONCOLOGY Future Leader 2025, shares how she’s combining technical skill with compassion to shape the future of cancer care for children. touchoncology.com/insight/dr-and… #Oncology #Radiotherapy #PaediatricCancer

💥 “If you want easy, oncology isn’t it. But if you thrive on challenge – start now.” 💥 Dr Elene Mariamidze shares her journey through mentorship, resilience & patient-centred care in this inspiring Q&A touchoncology.com/insight/dr-ele… Elene Mariamidze ESMO - Eur. Oncology Axel S. Merseburger #Oncology

🧡Early action can save lives Bladder cancer symptoms are often subtle—but they matter. If something feels off, don’t ignore it. This #WorldBladderCancerMonth, we’re reminding everyone: "Feeling unsure? Get checked." touchoncology.com/insight/bladde… World Bladder Cancer Patient Coalition Axel S. Merseburger

🎙️What’s next for continuing medical education? In the latest Visionary Voices episode, we explore the future of CME with the team behind touchIME — from global trends to the power of patient inclusivity. 🎧 touchoncology.com/podcast/whats-… #CME #MedicalEducation Matt Goodwin

In case you missed it... 🎯 RET+ NSCLC patients face unique challenges, including suboptimal response to IO. Dr. Christina Bestvina breaks down how RET inhibitors can change the game. 👩‍⚕️ Precision treatment starts here. 👉 Watch now: touchoncologyime.org/targeted-appro… Axel S. Merseburger

Antibody-drug conjugates are showing promise in head & neck cancer treatment. Explore current perspectives & future potential in this rapidly evolving field. 📖 Read more: touchoncology.com/head-and-neck-… #HeadAndNeckCancer #Oncology #MedicalInnovation #CancerTreatment #ClinicalResearch

🎉We've hit a combined 250,000 followers across all our platforms — and it’s all thanks to you! From sharing insights to advancing patient care, our global community of HCPs, researchers & partners makes it all possible Here’s to continuing the journey — together 💙 #ThankYou

🌟 Exciting news! 🌟 Our Visionary Voices podcast is now on Apple Music! 🎙️ Join us as we explore key trends & innovations in pharma & healthcare. 🎧 Tune in now: podcastsconnect.apple.com/my-podcasts/sh… #Podcast #VisionaryVoices #HealthcareInnovation #NowOnAppleMusic #Apple

🎯 “The patient always comes first – that lesson guides every decision I make.” Dr Ari Rosenberg (UChicago Medicine) shares how personalised, biomarker-driven care is transforming head and neck cancer outcomes. 🔗 touchoncology.com/insight/future… #HeadAndNeckCancer #Oncology #CancerCare

Have you seen our latest #YouTube video? Navigating the clinical impact of TROP2-targeting in NSCLC Watch now: youtu.be/slpScPwQtM4 #NSCLC #TROP2 #LungCancer #ELCC2025 #LungCancerResearch #CancerCare #Biomarkers

🧬New hope for older adults with relapsed/refractory AML Emerging cell therapy strategies may improve outcomes where traditional treatments fall short. Explore how novel approaches aim to overcome resistance & comorbidities in this high-risk group touchoncology.com/haematology/jo… #AML

💬 Dr Jemma Arakelyan shares how personal loss inspired her oncology career—fueling resilience, empathy & innovation in cancer care. 👉 Read more: touchoncology.com/insight/dr-jem… Jemma Arakelyan The University of Hong Kong #Oncology #FutureLeaders #CancerCare #touchONCOLOGY #WomenInMedicine

🧡 As #WorldBladderCancerMonth ends, our message continues: "Feeling unsure? Get checked." Awareness doesn't stop in May. Early symptoms matter. Early action saves lives. Thank you for joining us in #ChallengingUncertainty World Bladder Cancer Patient Coalition Axel S. Merseburger #BladderCancerMonth25

Have you listened to our latest #Podcast? 'RET-positive NSCLC: Translating insights into targeted approaches" Listen now: touchpodcast.podbean.com/e/ret-positive… #LungCancer #NSCLC #RETfusion #TargetedTherapy #OncologyEducation #PrecisionOncology #CancerCare

🌟 Meet Dr. Elene Mariamidze, a touchONCOLOGY Future Leader 2025! 🌟 Dr. Mariamidze shares insights on the role of mentorship & resilience in shaping her journey in oncology 📖 Read: touchoncology.com/insight/dr-ele… Elene Mariamidze ESMO - Eur. Oncology Axel S. Merseburger #Oncology #Mentorship #CancerCare

🧬 Immune checkpoint inhibitors are reshaping treatment for oesophageal squamous cell carcinoma (ESCC). Explore current evidence, challenges & future directions in immunotherapy: touchoncology.com/gastrointestin… #ESCC #Immunotherapy #CancerResearch #Oncology #touchONCOLOGY